AXIS/CO/CS/469/2026-27
Board Meeting Details
The Board meeting commenced at 09:00 am IST and results were approved at 12:30 pm IST on October 17, 2026. The financial results were subjected to limited review by joint statutory auditors M/s. MM Nissim & Co LLP and M/s. KKC & Associates LLP.
Standalone Financial Performance (₹ in crores)
Quarter Ended September 30, 2026:
- Interest Earned: 36,418.77
- Other Income: 6,530.55
- Total Income: 42,949.32
- Interest Expended: 21,047.35
- Operating Expenses: 10,818.89
- Operating Profit: 11,083.08
- Provisions and Contingencies: 1,693.74
- Profit Before Tax: 9,389.34
- Tax Expense: 2,386.06
- Net Profit: 7,003.28
Half-Year Ended September 30, 2026:
- Interest Earned: 70,404.40
- Other Income: 13,265.97
- Total Income: 83,670.37
- Interest Expended: 40,386.88
- Operating Expenses: 20,541.31
- Operating Profit: 22,742.18
- Provisions and Contingencies: 3,916.28
- Profit Before Tax: 18,825.90
- Tax Expense: 4,708.70
- Net Profit: 14,117.20
Key Ratios and Metrics
- Capital Adequacy Ratio (Basel III): 16.27% (Q2 FY27) vs 16.55% (Q2 FY26)
- Gross NPA Ratio: 1.16% (Q2 FY27) vs 1.46% (Q2 FY26)
- Net NPA Ratio: 0.35% (Q2 FY27) vs 0.44% (Q2 FY26)
- Return on Assets (annualized): 1.38% (Q2 FY27) vs 1.23% (Q2 FY26)
- EPS (Basic): ₹22.50 (Q2 FY27) vs ₹16.41 (Q2 FY26)
- EPS (Diluted): ₹22.38 (Q2 FY27) vs ₹16.32 (Q2 FY26)
Asset Quality
- Gross NPAs: ₹16,777.52 crore (Q2 FY27) vs ₹17,307.74 crore (Q2 FY26)
- Net NPAs: ₹5,053.79 crore (Q2 FY27) vs ₹5,113.86 crore (Q2 FY26)
Balance Sheet Position (as of September 30, 2026)
- Total Assets: ₹20,46,240.03 crore
- Deposits: ₹14,52,066.21 crore
- Borrowings: ₹2,73,085.52 crore
- Advances: ₹13,73,726.80 crore
- Investments: ₹4,53,464.34 crore
- Net Worth: ₹2,10,502.14 crore
- Paid-up Equity Capital: ₹622.74 crore (Face value ₹2 per share)
Capital Infusion and Share Allotment
During Q2 FY27, the Bank allotted 29,11,611 equity shares pursuant to exercise of options/units under Employee Stock Option/Units Scheme. During H1 FY27, total 55,17,102 equity shares were allotted.
The Bank infused equity capital of ₹25.49 crores in Freecharge Business and Technology Services Limited, a wholly-owned subsidiary.
RBI Resolution Framework Implementation
As of September 30, 2026, the Bank had exposure of ₹958.32 crore to accounts classified as standard consequent to implementation of resolution plans under RBI's COVID-19 resolution frameworks. Of this, ₹897.06 crore remained standard as of September 30, 2026.
Loan Acquisition and Transfer Activities
Loans not in default acquired:
- Corporate segment: ₹1,469.12 crore (96% rated A- and above)
- Retail segment: ₹2,855.53 crore
Loans not in default transferred:
- Corporate segment: ₹12,376.31 crore (94% rated A- and above)
Projects Under Implementation
As of September 30, 2026, the Bank had 829 projects under implementation with total outstanding of ₹25,160.58 crore.
Co-Lending Arrangements
As of September 30, 2026, the Bank had co-lending arrangements with 2 partners covering 702 outstanding cases with aggregate outstanding of ₹18.56 crore in Gold Loan and Personal Loan segments.
Subsidiary Structure
As of September 30, 2026, the Bank has 10 subsidiaries, 2 step-down subsidiaries and 1 associate.
RBI Provisioning Matter
The disclosure references an additional one-time standard asset provision of ₹1,231 crores made in Q2 FY26 for declassified PSL loans following RBI advisory post FY25 annual inspection. This provision will be written back upon all declassified loans being made compliant, recovered or closed by March 31, 2028.
Consolidated Financial Results (₹ in crores)
Quarter Ended September 30, 2026:
- Total Income: 45,674.37
- Net Profit: 7,649.70
- Consolidated Net Profit: 7,704.67
- EPS (Basic): ₹24.76
- EPS (Diluted): ₹24.63
Half-Year Ended September 30, 2026:
- Total Income: 88,887.19
- Net Profit: 15,306.21
- Consolidated Net Profit: 15,336.98
- EPS (Basic): ₹49.30
- EPS (Diluted): ₹49.03
Auditor Review
The unaudited financial results were subjected to limited review by joint statutory auditors who issued unmodified review reports.